Here’s a remarkable statistic you may not have heard: white children are two to three times more likely to be diagnosed with autism than are their Hispanic peers.
Autism’s core symptoms accompany a constellation of subtle signs that scientists are just beginning to unmask.
Individuals who carry a large and rare deletion on chromosome 16 that is associated with autism are likely to have developmental delays, be obese or both, according to two studies published last week in Nature.
Genetic variations that tweak the brain’s release of oxytocin — a hormone involved in social bonding and establishing trust — may increase the risk of developing autism or traits of the disorder, according to three new studies published in the past few months.
A large clinical trial to test the first drug specifically designed to treat autism is under way at 12 sites across the United States.
An early intervention method called the Early Start Denver Model can help children with autism improve their language and behavioral skills, and raise their intelligence quotients, according to a study published in Pediatrics.
Guoping Feng’s perseverance has proven a boon to the hundreds of neuroscientists who rely on his most celebrated scientific achievement: two dozen mouse strains engineered to have brightly colored brain cells. By creating the first robust mouse model of obsessive-compulsive disorder, Feng has also found a way to study repetitive behaviors, one of the three core characteristics of autism.